BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 726170)

  • 21. Cellular immunity to renal carcinomas in man.
    Bubeník J; Jakoubková J; Krákora P; Baresová M; Helbich P; Viklický V; Malasková V
    Int J Cancer; 1971 Nov; 8(3):503-13. PubMed ID: 5137312
    [No Abstract]   [Full Text] [Related]  

  • 22. In vitro evidence for increased cellular immunity to lung cancer antigen during Levamisole immunotherapy.
    Urist MM; Boddie AW; Townsend CM; Holmes EC
    J Thorac Cardiovasc Surg; 1977 Feb; 73(2):189-94. PubMed ID: 834057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Study on the tumor immunity of renal cell carcinoma--with special reference to the significance of leukocyte adherence inhibition test].
    Okada Y
    Hinyokika Kiyo; 1984 Oct; 30(10):1367-77. PubMed ID: 6395679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunity in colonic tumor patients after operation: determination by leukocyte-migration inhibition.
    House AK; Wisniewski S; Woodings TL
    Dis Colon Rectum; 1975 Mar; 18(2):100-6. PubMed ID: 1120439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Leukocyte migration inhibition and leukocyte adherence inhibition (LMI- and LAI-assay) in cancer patients by using preparations from human fetuses].
    Albrecht S; Thuy LT; Pasternak G; Schlott B; Reinhöfer J; Lunow E; Loewe G; Gütz HJ
    Acta Biol Med Ger; 1978; 37(11-12):1747-57. PubMed ID: 382722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell-mediated immunity in patients with renal adenocarcinoma.
    Bichler KH; Ax W; Tautz C
    Eur Urol; 1975; 1(5):231-4. PubMed ID: 61119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. General immunocompetence and tumour-directed, cell-mediated hypersensitivity in vitro in patients with renal carcinoma.
    Kjaer M; Thomsen M
    Acta Pathol Microbiol Scand C; 1976 Oct; 84C(5):403-13. PubMed ID: 136864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular immunity in bladder cancer patients.
    Guinan P; McKiel C; Flanagan M; Bhatti R; Pessis D; Ablin RJ
    J Urol; 1978 Jun; 119(6):747-9. PubMed ID: 660759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of leucocyte washings on cellular immunity to human renal carcinoma.
    Kjaer M
    Eur J Cancer (1965); 1976 Oct; 12(10):783-92. PubMed ID: 1086209
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibition of human leukocyte migration in agarose by kcl extracts of carcinoma of the lung.
    Boddie AW; Holmes EC; Roth JA; Morton DL
    Int J Cancer; 1975 May; 15(5):823-9. PubMed ID: 1140874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequential study of macrophage migration inhibition factor in renal cell carcinoma patients.
    Gillon G; Livni E; Servadio C
    Eur Urol; 1988; 14(5):391-4. PubMed ID: 3049110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Indirect leukocyte migration inhibition reactions to a 3-M KCl extract of lung adenocarcinoma by lung cancer patients.
    Suslov I; McCoy JL; Herberman RB
    J Natl Cancer Inst; 1981 Feb; 66(2):233-7. PubMed ID: 7005504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Agarose microdroplet leucocyte migration technique for detection of cell-mediated hypersensitivity to PPD and renal carcinoma antigen.
    Sorensen TB; Kjaer M
    Clin Exp Immunol; 1977 Oct; 30(1):168-72. PubMed ID: 606436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of leukocyte migration by extracts of malignant prostatic tissue and correlation of degree of in vitro sensitization to clinical responsiveness in prostatic cancer patients.
    Ablin RJ; Bush IM; Bruns GR; John T; Sadoughi N; Guinan PD
    Urology; 1978 Mar; 11(3):289-92. PubMed ID: 565097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The LMI test in colon, breast and lung cancer long survivors.
    Fazio M; Calabrese F; Coluccia C; Giacomasso S; Casadio C; Mancuso M; Negri L; Mastromatteo V
    Panminerva Med; 1992; 34(2):60-4. PubMed ID: 1408329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pre-operative irradiation and tumor-specific immune response in hypernephroid renal carcinoma (author's transl)].
    Dietz R; Schwarze G; Pappas A
    Strahlentherapie; 1979 Jul; 155(7):466-9. PubMed ID: 115119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunological monitoring and immunotherapy in carcinoma of the lung.
    Weese JL; Herberman RB; Perlin E; Mills M; Heims W; Blom J; Green D; Reid J; Bellinger S; Law I; McCoy JL; Dean JH; Cannon GB; Djeu J
    Int J Cancer; 1976 Dec; 18(6):739-49. PubMed ID: 186417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leukocyte migration inhibition in relation to nuclear pleomorphism and lymphoid infiltration in breast cancer.
    Egami H; Sakamoto K; Kimura M; Nishimura R; Akagi M
    Jpn J Clin Oncol; 1985 Jun; 15(2):393-401. PubMed ID: 2410639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The macrophage electrophoretic mobility assay in patients with renal cell carcinoma.
    Malkovský M; Bubeník J; Jakoubková J; Suhajová E; Indrová M; Jandlová T; Símová J
    Neoplasma; 1981; 28(2):245-51. PubMed ID: 7254439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of human tumor-associated antigens by the leukocyte migration in agarose assay.
    Boddie AW; Urist MM; Chee DO; Holmes C; Morton DL
    Int J Cancer; 1976 Aug; 18(2):161-7. PubMed ID: 60286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.